Stockscreener 앱 받기
2.17
1.88%
0.04
Esperion Therapeutics Inc (ESPR) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
5.96%
65.00
|
69.11 | 51.63 | 73.83 | 137.74 |
Operating Expenses
|
18.44%
87.09
|
73.53 | 67.66 | 71.25 | 65.47 |
| Benefits Costs and Expenses |
-
|
- | - | - | - |
| Costs And Expenses |
18.44%
87.09
|
73.53 | 67.66 | 71.25 | 65.47 |
| Operating Income/Loss |
399.91%
-22.10
|
-4.42 | -16.03 | 2.579 | 72.27 |
| Income/Loss From Continuing Operations Before Tax |
5.96%
65.00
|
69.11 | 51.63 | -61.92 | 61.02 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
89.77%
-40.45
|
-21.32 | -29.52 | -61.92 | 61.02 |
|
Net Income/Loss
|
89.77%
-40.45
|
-21.32 | -29.52 | -61.92 | 61.02 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
6,866%
196.13
|
2.8154 | 194.93 | 188.79 | 169.26 |
| Diluted Average Shares |
6,866%
196.13
|
2.8154 | 194.93 | 188.79 | 189.64 |
| Basic Earnings Per Share |
90.91%
-0.21
|
-0.11 | -0.15 | -0.33 | 0.36 |
| Diluted Earnings Per Share |
90.91%
-0.21
|
-0.11 | -0.15 | -0.33 | 0.34 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.37%
0.37%
자본화:
|
볼륨(24시간):